CN Stock MarketDetailed Quotes
600796 Zhejiang Qianjiang Biochemical
- 4.03
- -0.04-0.98%
Market Closed Sep 13 15:00 CST
3.49BMarket Cap16.72P/E (TTM)
4.08High4.01Low16.42KlotVolume4.05Open4.07Pre Close6.64MTurnover0.55%Turnover Ratio16.58P/E (Static)866.59MShares6.0452wk High1.09P/B1.21BFloat Cap3.6252wk Low4.48Limit Up301.40MShs Float20.67Historical High3.66Limit Down1.72%Amplitude1.49Historical Low0.03Dividend TTM4.04Avg Price11.39KlotAsk0.77%Div YieldTTM100Lot Size4.84KlotBid
Zhejiang Qianjiang Biochemical Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -0.55%862.66M | 4.52%373.99M | 1.27%2.03B | -1.19%1.33B | -1.36%867.39M | -7.72%357.82M | -1.09%2.01B | 3.14%1.34B | 2.70%879.38M | 17.25%387.75M |
| Operating revenue | -0.55%862.66M | 4.52%373.99M | 1.27%2.03B | -1.19%1.33B | -1.36%867.39M | -7.72%357.82M | -1.09%2.01B | 3.14%1.34B | 2.70%879.38M | 17.25%387.75M |
| Other operating revenue | 75.40%7.72M | ---- | -16.15%3.74M | ---- | -24.93%4.4M | ---- | -59.67%4.46M | ---- | -57.88%5.86M | ---- |
| Total operating cost | -0.90%797.05M | 4.25%357.22M | 0.15%1.85B | -3.73%1.21B | -2.87%804.31M | -9.90%342.66M | 0.66%1.85B | 5.16%1.25B | 4.60%828.07M | 16.26%380.3M |
| Operating cost | -0.86%660.88M | 7.16%296.9M | -0.78%1.56B | -5.66%1B | -5.19%666.63M | -13.73%277.05M | 0.25%1.57B | 5.36%1.06B | 4.48%703.13M | 18.06%321.13M |
| Operating tax surcharges | 10.42%7.43M | 24.43%2.93M | 11.44%16.47M | -0.90%9.39M | 3.51%6.73M | -18.46%2.35M | -4.84%14.78M | -7.12%9.48M | -3.51%6.5M | 4.93%2.89M |
| Operating expense | 37.48%7.26M | 20.50%3.23M | 12.34%17.18M | 123.22%8.72M | 71.25%5.28M | 32.02%2.68M | 111.15%15.29M | -17.12%3.91M | -19.62%3.09M | -32.78%2.03M |
| Administration expense | -1.91%68.49M | -3.86%31.65M | 10.69%149.27M | 13.69%103.85M | 22.41%69.82M | 25.65%32.92M | 3.95%134.86M | 10.48%91.35M | 2.97%57.04M | 3.41%26.2M |
| Financial expense | -10.11%36.56M | -16.01%17.5M | 0.00%86.56M | -5.72%60.69M | -8.01%40.68M | -2.08%20.84M | -4.07%86.55M | 3.20%64.37M | 19.54%44.22M | 33.38%21.28M |
| -Interest expense (Financial expense) | -6.20%41.46M | -23.95%22.75M | -5.36%96.77M | -23.36%63.68M | -31.15%44.2M | 16.56%29.92M | 6.76%102.25M | 27.44%83.09M | 35.57%64.2M | 31.36%25.67M |
| -Interest Income (Financial expense) | -41.56%-6.75M | 33.05%-6.93M | 31.08%-10.33M | 66.37%-11.06M | 76.17%-4.76M | -5.56%-10.35M | -228.24%-14.99M | -136.31%-32.89M | -120.93%-20M | -111.43%-9.81M |
| Research and development | 8.16%16.41M | -26.50%5.01M | -9.66%28.41M | -1.04%22.23M | 7.64%15.17M | 0.59%6.81M | -1.81%31.45M | -6.81%22.46M | -10.12%14.09M | -15.87%6.77M |
| Credit Impairment Loss | -250.31%-10.22M | 60.54%-873.47K | -878.92%-19M | -5,431.83%-14.02M | -93.23%-2.92M | -169.14%-2.21M | 33.86%-1.94M | -103.41%-253.51K | -180.15%-1.51M | 1,218.30%3.2M |
| Asset Impairment Loss | 215.47%2.9M | -103.18%-8.37K | -103.63%-9.34M | -495.08%-1.33M | -581.82%-2.51M | 136.93%263.04K | -757.32%-4.59M | -66.36%335.96K | -51.63%520.76K | 77.06%-712.19K |
| Other net revenue | -40.67%21.89M | 3.53%11.65M | -42.23%49.91M | -33.39%46.55M | -16.27%36.9M | -64.08%11.26M | 308.13%86.39M | 208.39%69.89M | 225.57%44.07M | 3,905.75%31.34M |
| Invest income | -12.93%22.37M | 1.14%9.6M | -9.29%50.2M | 0.90%40.51M | -8.05%25.7M | -43.10%9.49M | 7,235.38%55.34M | 11,768.17%40.15M | 3,174.82%27.95M | 49,029.25%16.68M |
| -Including: Investment income associates | -5.79%22.08M | ---- | -8.21%47.95M | ---- | -5.03%23.44M | ---- | 1,047,005.39%52.23M | ---- | 136,028.60%24.68M | ---- |
| Asset deal income | -99.35%60.96K | -30.99%60.96K | -1.71%9.34M | 5.65%9.46M | 5.31%9.43M | -99.08%88.34K | 1,636.77%9.51M | 866.63%8.96M | 866.63%8.96M | 1,272.46%9.59M |
| Other revenue | -5.84%6.77M | -20.72%2.88M | -33.40%18.7M | -42.38%11.93M | -11.80%7.19M | 40.62%3.63M | 20.29%28.07M | 59.74%20.7M | -7.32%8.15M | -24.98%2.58M |
| Operating profit | -12.47%87.5M | 7.59%28.42M | -5.63%230.84M | 4.61%168.94M | 4.82%99.97M | -31.90%26.42M | 14.56%244.61M | 19.87%161.5M | 21.99%95.37M | 788.78%38.79M |
| Add:Non operating Income | 1,483.16%1.61M | -82.10%1.53M | 61.73%2.26M | -24.59%743.61K | -86.58%101.59K | 2,607.48%8.55M | -61.94%1.4M | 6.90%986.03K | -14.23%756.81K | -65.14%315.88K |
| Less:Non operating expense | 6.14%699.06K | -72.23%150.53K | -25.65%4.27M | -84.98%735.49K | 152.30%658.64K | 139.57%542.08K | -23.17%5.74M | 249.87%4.9M | -63.86%261.05K | -65.00%226.27K |
| Total profit | -11.06%88.41M | -13.43%29.8M | -4.76%228.84M | 7.21%168.95M | 3.70%99.41M | -11.45%34.43M | 14.56%240.27M | 17.39%157.59M | 22.38%95.87M | 740.81%38.88M |
| Less:Income tax cost | -4.07%22.8M | -2.15%9.11M | -8.44%45.94M | 17.07%41.79M | 3.38%23.77M | 34.95%9.31M | 6.79%50.17M | -0.21%35.7M | 13.81%22.99M | 3.27%6.9M |
| Net profit | -13.26%65.61M | -17.61%20.69M | -3.79%182.9M | 4.32%127.16M | 3.80%75.65M | -21.46%25.12M | 16.81%190.1M | 23.78%121.89M | 25.35%72.88M | FLtoP31.98M |
| Net profit from continuing operation | -13.26%65.61M | -17.61%20.69M | -3.79%182.9M | 4.32%127.16M | 3.80%75.65M | -21.46%25.12M | 16.81%190.1M | 23.78%121.89M | 25.35%72.88M | 1,654.82%31.98M |
| Less:Minority Profit | -88.62%-16.64M | -54.81%-8.09M | -74.25%-27.79M | -54.08%-12.45M | -42.87%-8.82M | -45.97%-5.22M | -207.72%-15.95M | -215.83%-8.08M | -234.99%-6.17M | 6.78%-3.58M |
| Net profit of parent company owners | -2.62%82.25M | -5.15%28.78M | 2.25%210.69M | 7.41%139.6M | 6.85%84.47M | -14.67%30.34M | 39.28%206.05M | 42.04%129.97M | 47.58%79.05M | 1,895.59%35.56M |
| Add:Adjusted items effecting net profit of parent company owners | ---- | ---- | ---- | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- |
| Earning per share | ||||||||||
| Basic earning per share | -10.00%0.09 | -25.00%0.03 | 0.00%0.24 | 6.67%0.16 | 11.11%0.1 | 0.00%0.04 | 9.09%0.24 | 7.14%0.15 | 12.50%0.09 | 566.67%0.04 |
| Diluted earning per share | -10.00%0.09 | -25.00%0.03 | 0.00%0.24 | 6.67%0.16 | 11.11%0.1 | 0.00%0.04 | 9.09%0.24 | 7.14%0.15 | 12.50%0.09 | 566.67%0.04 |
| Other composite income | ||||||||||
| Total composite income | -13.26%65.61M | -17.61%20.69M | -3.79%182.9M | 4.32%127.16M | 3.80%75.65M | -21.46%25.12M | 13.22%190.1M | 17.04%121.89M | 25.62%72.88M | 1,622.74%31.98M |
| Total composite income of parent company owners | -2.62%82.25M | -5.15%28.78M | 2.25%210.69M | 7.41%139.6M | 6.85%84.47M | -14.67%30.34M | 34.75%206.05M | 33.74%129.97M | 47.82%79.05M | 1,930.14%35.56M |
| Total composite income of minority owners | -88.62%-16.64M | -54.81%-8.09M | -74.25%-27.79M | -54.08%-12.45M | -42.87%-8.82M | -45.97%-5.22M | -206.44%-15.95M | -215.83%-8.08M | -236.08%-6.17M | 7.09%-3.58M |
| Add:Adjusted items effecting total composite income | ---- | ---- | ---- | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- |
| Auditor | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data